Featured
-
-
Review Article |
Illuminating the dark spaces of healthcare with ambient intelligence
Breakthroughs in artificial intelligence and low-cost, contactless sensors have given rise to an ambient intelligence that can potentially improve the physical execution of healthcare delivery, if used in a thoughtful manner.
- Albert Haque
- , Arnold Milstein
- & Li Fei-Fei
-
Inside View |
Inside View: Centro Medico Teknon
-
Books & Arts |
Genetics: Testing infant destinies
Henry Greely hails a study examining California's experience of mandatory newborn genetic screening.
- Henry T. Greely
-
Brief Communications Arising |
Is irisin a human exercise gene?
- James A. Timmons
- , Keith Baar
- & Philip J. Atherton
-
-
News |
Cholera vaccine deployed to control African outbreak
Patients in Guinea are first in Africa to be given oral vaccination during an epidemic.
- Gozde Zorlu
-
-
News |
Road map unveiled to tackle neglected diseases
The WHO hopes to control or eliminate ten diseases by 2020.
- Daniel Cressey
-
Correspondence |
Biobank donors should have a say
- Brenda Spencer
- , Daria Koutaissoff
- & Hans-Anton Lehr
-
News Explainer |
Say hello to intelligent pills
Digital system tracks patients from the inside out.
- Daniel Cressey
-
News |
Can a vaccine cure Haiti's cholera?
Two years after the earthquake and thousands of deaths later, the debate about whether to use the cholera vaccine in Haiti continues.
- Katherine Harmon
-
Correspondence |
Control the bonanza for research eggs
- Marcy Darnovsky
- , Susan Berke Fogel
- & Judy Norsigian
-
News Feature |
Tissue-bank shortage: Brain child
Asking parents to donate a child's brain to research is emotionally fraught. Some researchers say that it is time to put aside the taboos.
- Alison Abbott
-
News |
Fetal gene screening comes to market
Non-invasive procedure could make prenatal testing easier, but it comes with ethical problems.
- Erika Check Hayden
-
News Feature |
Death of a pathology centre: Shelved
For decades, the Armed Forces Institute of Pathology has been a leader in disease diagnosis. Now it is closing, and its legacy is in jeopardy.
- Alison McCook
-
-
News Feature |
Nutrition advice: The vitamin D-lemma
A vociferous debate about vitamin-D supplementation reveals the difficulty of distilling strong advice from weak evidence.
- Amy Maxmen
-
News |
Rare-disease studies seek online giving
Website invites micro-donations for unusual illnesses.
- Amber Dance
-
News Q&A |
Spit test offers guide to health
Telomeres may not predict how long we'll live, but they can still revolutionise medicine, says Nobel laureate Elizabeth Blackburn.
- Jo Marchant
-
News |
Cholera care fails to reach rural Haitians
Celebrations over the country's shrinking caseload need to be qualified, a new analysis shows.
- David Cyranoski
-
News |
From battlefield to bedside
Medical research in the British military soldiers on despite defence cuts.
- Daniel Cressey
-
Comment |
Short-lived campaigns are not enough
The stigma of mental illness will be reduced only if region-specific awareness initiatives become a permanent fixture of health and social services, argues Norman Sartorius.
- Norman Sartorius
-
News |
Cancer-gene testing ramps up
Thousands to get personalized medicine in Britain's National Health Service.
- Ewen Callaway
-
News |
Kids swap DNA for fairground rides
Researchers' efforts to collect samples at a fair raise ethical questions.
- Ewen Callaway
-
-
Editorial |
Standard issue
The industry behind direct-to-consumer gene tests needs to establish guidelines for its wares.
-
Feature |
Country by country
Anna Petherick investigates the nature of Chagas disease and how its management varies across Latin America.
- Anna Petherick
-
Feature |
Campaigning for Chagas disease
Energized individuals have worked hard to raise awareness. But politicians have not always listened.
- Anna Petherick
-
Editorial |
Handle with care
Britain's Department of Health must respond to concerns about electronic medical records.
-
Editorial |
Learning to share
By opening up its database of potential malaria drugs, GlaxoSmithKline has blazed a path that other pharmaceutical companies should follow.
-
News |
Aid fund faces cash crunch
Fight against tuberculosis, malaria and AIDS under threat from success.
- Declan Butler
-
News |
Lawsuit rekindles gene-patent debate
Criticism of exclusive licences puts university policies in the spotlight.
- Brendan Borrell
-
Editorial |
Lessons from a pandemic
It is time to assess what worked, and what didn't, in the global efforts to cope with swine flu.
Quasi-experimental evaluation of a nationwide diabetes prevention programme